1 Peripheral muscle force |
6 |
159 |
Std. Mean Difference (IV, Random, 95% CI) |
0.34 [0.02, 0.65] |
2 Peripheral muscle endurance/fatigability |
2 |
35 |
Std. Mean Difference (IV, Random, 95% CI) |
1.36 [0.59, 2.12] |
3 Thigh muscle size |
4 |
124 |
Std. Mean Difference (IV, Random, 95% CI) |
0.25 [‐0.11, 0.61] |
4 Mortality |
5 |
131 |
Risk Difference (M‐H, Random, 95% CI) |
‐0.02 [‐0.08, 0.05] |
5 Exercise capacity: 6‐minute walking distance (6MWD) (m) |
2 |
72 |
Mean Difference (IV, Random, 95% CI) |
39.26 [16.31, 62.22] |
6 Exercise capacity: VO2peak (L/min) |
4 |
73 |
Mean Difference (IV, Random, 95% CI) |
0.10 [0.00, 0.19] |
7 Exercise capacity: peak power (W) |
2 |
33 |
Mean Difference (IV, Random, 95% CI) |
5.77 [‐4.00, 17.53] |
8 Exercise capacity: endurance time (min) |
3 |
55 |
Mean Difference (IV, Random, 95% CI) |
3.62 [2.33, 4.91] |
9 Symptoms: dyspnoea reported at end exercise |
3 |
55 |
Mean Difference (IV, Random, 95% CI) |
‐1.03 [‐2.13, 0.06] |
10 Symptoms: leg fatigue reported at end exercise |
3 |
55 |
Mean Difference (IV, Random, 95% CI) |
‐1.12 [‐1.81, ‐0.43] |
11 Health‐related quality of life: SGRQ |
2 |
72 |
Mean Difference (IV, Random, 95% CI) |
‐4.12 [‐12.60, 4.35] |
12 Minor adverse events: related to intervention |
5 |
139 |
Risk Difference (M‐H, Random, 95% CI) |
0.00 [‐0.07, 0.07] |